Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

October 16, 2023
Virginia Cancer Specialists » VCS Practice News » Clinical Trials and Research » VCS Practice News » Clinical Trials Search » Investigational Inhibitor of Active RAS Shows Clinical Promise – Alexander I. Spira, MD, PhD, FACP

Investigational Inhibitor of Active RAS Shows Clinical Promise –  The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C

 thumbnail of Targets23_Spira_RasON_FINAL

Alexander I Spira MD, PhD, FACP, FASCO Headshot

Alexander I Spira MD, PhD, FACP, FASCO

Medical Oncologist

Recent Posts

Head and Neck Cancer: Symptoms and Treatment Options
Head and Neck Cancer: Symptoms and Treatment Options
April 1, 2024
Read More
Boost Your Wellbeing: Mindfulness Mondays - Relaxation Sessions for Patients, Caregivers, and Families
Boost Your Wellbeing: Mindfulness Mondays - Relaxation Sessions for Patients, Caregivers, and Families
March 28, 2024
Read More
OncLive State of the Science Summit - Breast and Lung Cancer Event, March 2024
OncLive State of the Science Summit - Breast and Lung Cancer Event, March 2024
March 27, 2024
Read More
Lymphedema Awareness Month -Shedding Light on Breast Cancer-Related Arm Lymphedema: A Call for Awareness and Action
Lymphedema Awareness Month -Shedding Light on Breast Cancer-Related Arm Lymphedema: A Call for Awareness and Action
March 19, 2024
Read More
OncLive State of the Science Summit - Breast and Lung Cancer Event, Thursday, March 14, 2024 • 6:00 PM – 9:00 PM ET
OncLive State of the Science Summit - Breast and Lung Cancer Event, Thursday, March 14, 2024 • 6:00 PM – 9:00 PM ET
March 4, 2024
Read More
Return to Top